DocDollars

Adlon Therapeutics L.P.

CT · United States · Reporting entity ID 100000506820

Total reported 2019–2025
$4.43M
#748 of 2,960 reporting companies — 0% of all reported industry payments
$777K in general payments across 25,893 records, plus $3.65M in research funding across 130 records.

How it breaks down

General payments $777,261
Research funding $3,653,485

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Adlon Therapeutics L.P. reported $4.43M to US doctors and teaching hospitals from 2019 to 2025, ranking #748 of 2,960 reporting companies. 82% of that was research funding and 18% general payments such as consulting, speaking, food and travel. 25,893 general payment records and 130 research records were filed.

Common questions about Adlon Therapeutics L.P.

How much has Adlon Therapeutics L.P. paid US doctors?

Adlon Therapeutics L.P. reported $4,430,746 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $777,261 in general payments, $3,653,485 in research funding.

How does Adlon Therapeutics L.P. rank among drug and device companies?

It ranks #748 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Adlon Therapeutics L.P. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.